MedPath

This study of dushta vrana cure with the help of nimbaadi taila make comparision with eusol liquid

Phase 2
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Registration Number
CTRI/2021/12/038403
Lead Sponsor
Vinod Patel
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Both male and female.

2)Between the age group of 12 to 80 yrs will be included in the study.

3)Patients of dushtavrana with a minimum history of 3 weeks.

4)Dushtavrana size 5x5 (LxL)cms.

5) Selection is irrespective of religion, socio-economical status an occupation.

6) Controlled diabetic patients.

Exclusion Criteria

1 Patient not willing fortrial

2 Patient who need surgical and other inintervention.

3 Anaemic patient Hb <10 gm

4 Malnourished patient (as per age ,height and weight proportion.)

5 Bleeding disorders (increased B.T and C.T)

6 Patient with septicemia

7 The patients suffering from systemic disease such as AIDS,Tuberculosis,Diabetes mellitus, Hepatitis-B, Malignancy, Vericose ulcer, Deep vein

thrombosis,Arterial ulcer,Neurogenic ulcer, Leprosy, Pregnancy,Leukemia Acute

and Chronic renal failure,Jaundice and cirrhosis of liver, etc..

8 Any congenital diseases or abnormalities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1-Vrana has been defined as the wound which after healing leaves permanent scar.The word dushta vrana is composed of two different word and two different meanings. <br/ ><br>2-To evaluate and establish safer,cost-effective nimbaadi taila in the management of Dushta VranaTimepoint: 15 days(1,3,5,7,9,11,13,15 th days)
Secondary Outcome Measures
NameTimeMethod
In this group 15 patients wound will be washed with normal saline followed by local application of eusol liquid.Timepoint: 15 days (1,3,5,7,9,11,13,15th) with follow up
© Copyright 2025. All Rights Reserved by MedPath